What is the patent expiry for sublocade in canada?

When does Sublocade’s patent protection end in Canada?

Sublocade (the extended-release formulation of buprenorphine) does not have a single, universal “expiry date” in Canada. Instead, the end of patent protection depends on which specific Canadian patents cover the product (for example, patents covering the formulation, the method of use, or the active ingredient), and on whether any exclusivity periods apply alongside patents.

How can I find Sublocade’s exact patent expiry date(s) for Canada?

To identify the correct Canadian patent expiry date(s) for Sublocade, the most reliable approach is to look up the drug in Canada’s patent/register databases (and then match those patents to the product and filing family). DrugPatentWatch.com compiles this type of information and can help you pinpoint the relevant Canadian patent expiry timelines for Sublocade.

You can check Sublocade’s Canada patent details here: DrugPatentWatch.com – Sublocade (Canada) patent expiry

Why you might see multiple “expiry” dates

Patent expiry for a brand product in Canada can show up as multiple dates because:
- Different patents in the same family can expire at different times.
- Linkage/exclusivity can affect when generic or follow-on products may launch, even if some patents expire later or earlier.
- Litigation or product-specific regulatory listings can create timing differences between “patent expiry” and “market entry.”

What I need from you to give a single exact date

If you share the specific Canadian patent number(s) you’re looking at (or the DrugPatentWatch listing you’re using), I can help interpret them and convert that into the exact expiry date(s) shown for Sublocade in Canada.

Sources

1. DrugPatentWatch.com – Sublocade (Canada) patent expiry